首页> 外文期刊>Journal of Drug Delivery and Therapeutics >To study the comparative dissolution profiles of sustained release tablets of metformin hydrochloride by using various hydrophilic polymers
【24h】

To study the comparative dissolution profiles of sustained release tablets of metformin hydrochloride by using various hydrophilic polymers

机译:通过使用各种亲水性聚合物研究盐酸二甲双胍缓释片的比较溶出曲线

获取原文
       

摘要

In this research study an attempt was made to formulate sustained release matrix tablets of Metformin Hydrochloride as it possesses relatively shorter plasma half-life, low bioavailability. The sustained release formulations of the drug were capable of maintaining the plasma level for 8-12 hours. The overall objective of this research was to formulate the tablet by using various hydrophilic polymers i.e. Xanthan gum, Guar gum, Aloe barbadensis and Methocel K4M. Tablets were prepared by wet granulation method. In Vitro studies were performed by USP XX apparatus I, basket and the data was analyzed using zero order, first order, and Korsmeyer and Higuchi models. Nine formulations were made, out of which F-9 formulation which was composed of Aloe Barbadensis in the ratio of 1:2, with combination of other polymers (xanthan gum, guar gum and methocel K4 M) showed maximum drug release within 12 hours with sustained release profile because Aloe barbadensis showed maximum swelling followed by entanglement of polymers chains, thus gave maximum gel strength which provides main retarding factor for the drug release. The use of three polymers (xanthan gum, guar gum and methocel K4M) alone in the different formulations i.e. from F-1 to F-6 was not able to sustain the drug release because of their rapid solubilization in acidic pH leads to pores in the matrix, finally causes surface erosion and initial disaggregation of the matrix tablet prior to gel layer formation around tablet core causes rapid release of the drug within 1 hour as compared to F-9 formulation.
机译:在这项研究中,人们尝试配制盐酸二甲双胍的缓释基质片剂,因为它具有相对较短的血浆半衰期,较低的生物利用度。该药物的缓释制剂能够将血浆水平维持8-12小时。这项研究的总体目标是通过使用各种亲水性聚合物(如黄原胶,瓜尔胶,巴巴芦荟和Methocel K4M)配制片剂。通过湿法制粒制备片剂。使用USP XX仪器I,篮进行体外研究,并使用零阶,一阶以及Korsmeyer和Higuchi模型分析数据。制备了9种制剂,其中F-9制剂由1:2的库拉索芦荟组成,与其他聚合物(黄原胶,瓜尔胶和Methocel K4 M)的组合在12小时内显示出最大的药物释放。持续释放曲线是因为巴巴芦荟显示出最大的溶胀,接着是聚合物链的缠结,因此产生了最大的凝胶强度,这为药物释放提供了主要的阻滞因子。在三种不同的配方(即F-1至F-6)中单独使用三种聚合物(黄原胶,瓜尔胶和Methocel K4M)无法维持药物释放,因为它们在酸性pH中的快速溶解会导致药液中出现孔。与F-9制剂相比,基质最终会导致表面侵蚀,并且在片剂核心周围形成凝胶层之前,基质片剂的初始崩解会导致药物在1小时内快速释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号